Dunlap Ryan 4
4 · CytoDyn Inc. · Filed Jan 5, 2024
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
Dunlap Ryan
Director
Transactions
- Award
Non-qualified stock option (right to buy)
2024-01-03+800,000→ 800,000 totalExercise: $0.21Exp: 2034-01-03→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024.